Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $0.000001 $0.000001 Friday, 27th May 2022 ANTH stock ended at $0.000001. During the day the stock fluctuated 0% from a day low at $0.000001 to a day high of $0.000001.
90 days $0.000001 $0.000001
52 weeks $0.000001 $0.0850

Historical Anthera Pharmaceuticals prices

Date Open High Low Close Volume
Sep 30, 2016 $25.20 $25.20 $25.20 $25.20 57 688
Sep 29, 2016 $24.80 $24.80 $24.80 $24.80 67 250
Sep 28, 2016 $24.96 $24.96 $24.96 $24.96 45 950
Sep 27, 2016 $26.00 $26.00 $26.00 $26.00 64 463
Sep 26, 2016 $25.28 $25.28 $25.28 $25.28 28 150
Sep 23, 2016 $25.52 $25.52 $25.52 $25.52 53 575
Sep 22, 2016 $25.12 $25.12 $25.12 $25.12 52 925
Sep 21, 2016 $24.64 $24.64 $24.64 $24.64 62 975
Sep 20, 2016 $23.60 $23.60 $23.60 $23.60 54 550
Sep 19, 2016 $23.68 $23.68 $23.68 $23.68 76 863
Sep 16, 2016 $24.48 $24.48 $24.48 $24.48 81 188
Sep 15, 2016 $26.32 $26.32 $26.32 $26.32 55 200
Sep 14, 2016 $25.60 $25.60 $25.60 $25.60 57 738
Sep 13, 2016 $24.96 $24.96 $24.96 $24.96 39 600
Sep 12, 2016 $25.52 $25.52 $25.52 $25.52 82 963
Sep 09, 2016 $24.00 $24.00 $24.00 $24.00 74 563
Sep 08, 2016 $24.88 $24.88 $24.88 $24.88 64 588
Sep 07, 2016 $23.84 $23.84 $23.84 $23.84 29 125
Sep 06, 2016 $23.60 $23.60 $23.60 $23.60 32 925
Sep 02, 2016 $23.44 $23.44 $23.44 $23.44 22 138
Sep 01, 2016 $23.28 $23.28 $23.28 $23.28 35 663
Aug 31, 2016 $23.04 $23.04 $23.04 $23.04 50 875
Aug 30, 2016 $24.16 $24.16 $24.16 $24.16 27 213
Aug 29, 2016 $24.00 $24.00 $24.00 $24.00 32 725
Aug 26, 2016 $23.76 $23.76 $23.76 $23.76 67 438
Click to get the best stock tips daily for free!

About Anthera Pharmaceuticals

Anthera Pharmaceuticals Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated auto... ANTH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT